HomeInsightFUNDING NEWS- Newly Funded Startups 2024 Scimplify Raises $7 Mn Series A Funding Round from Omnivore

[Funding News] Scimplify Raises $7 Mn Series A Funding Round from Omnivore

Scimplify, a comprehensive platform for sourcing and manufacturing specialty chemicals, has successfully secured Rs 59 crore (roughly $7 million) in its Series A funding round from a combination of new and existing investors.

The board of Scimplify has approved a special resolution to sell 17,514 Series A CCPS (Compulsorily Convertible Preference Shares) at an issue price of Rs 33,676 apiece, with the aim of raising Rs 59 crore or $7 million.

Omnivore secured the highest investment of Rs 24.7 crore, followed by 3One4 Capital, Beenext Asia, and Bertelsmann with investments of Rs 13.56 crore, Rs 5.6 crore, and Rs 14.82 crore, respectively.

Read also – Kinetic Green Secures $20 Mn Funding Round from Greater Pacific Capital

Scimplify is a business-to-business (B2B) fulfillment platform that operates throughout the whole product life cycle, spanning from contract research to commercial chemical manufacture. It serves many industries, including pharmaceuticals, personal care, and agrochemicals.

Scimplify provides a range of products including emulsifiers, plant growth stimulators, biostimulants, adjuvants, and biofertilizers, among others.

About Scimplify

Founded in 2023 by Salil Srivastava and Sachin Santhosh, Scimplify is a science-first platform for end-to-end sourcing and manufacturing of specialty chemicals.

Want to go deeper into the world of startups and entrepreneurship? Check out these categories on VIESTORIES:

Startup Success Stories: Discover inspiring tales of startups overcoming challenges and achieving success.

Funding Startup News: Stay updated with the latest news and trends in startup funding and investment.

Startup Insights: Dive into in-depth analyses of various industries and market trends to make informed business decisions.

Team VS

RELATED ARTICLES
- Advertisment -

Most Popular

- Advertisment -

Also Read

- Advertisment -